Diagnosing Heart Failure Stage B
Heart failure Stage B is diagnosed through identification of structural heart disease without current or past symptoms of heart failure, using echocardiography as the primary diagnostic tool, along with supporting tests including electrocardiography, chest radiography, and natriuretic peptide measurement. 1
Definition of Stage B Heart Failure
Stage B heart failure represents patients with:
- Structural heart disease
- No current or past symptoms of heart failure
- Normal physical activity without limitations (NYHA class I)
- A critical pre-symptomatic phase requiring intervention to prevent progression 1
Diagnostic Approach
Primary Diagnostic Tests
Two-dimensional echocardiography with Doppler
12-lead electrocardiogram
- Should be performed in all patients
- May show evidence of prior MI, LV hypertrophy, or cardiac conduction abnormalities 2
Chest radiography (PA and lateral)
- Evaluates cardiac size and pulmonary congestion
- Should be performed in all patients 2
Laboratory Evaluation
Initial laboratory assessment
- Complete blood count
- Urinalysis
- Serum electrolytes (including calcium and magnesium)
- Blood urea nitrogen and serum creatinine
- Fasting blood glucose (glycohemoglobin)
- Lipid profile
- Liver function tests
- Thyroid-stimulating hormone 2
Natriuretic peptide measurement (BNP or NT-proBNP)
Additional Diagnostic Testing (When Indicated)
Coronary assessment
Specialized testing (when clinically suspected)
Common Presentations of Stage B Heart Failure
Patients with Stage B heart failure typically include those with:
- Previous myocardial infarction
- Left ventricular systolic dysfunction (LVEF <40%) without symptoms
- Valvular heart disease without symptoms
- Other known structural heart disease 1
Diagnostic Pitfalls to Avoid
- Don't rely solely on clinical examination: Structural heart disease may be present without obvious clinical signs 2
- Don't skip echocardiography: It is the diagnostic standard for confirming structural heart disease 4
- Don't perform routine endomyocardial biopsy: Not recommended in routine evaluation 2
- Don't routinely measure circulating neurohormones: Not recommended for routine evaluation 2
- Don't rely on signal-averaged electrocardiography: Not recommended for routine evaluation 2
Follow-up Assessment
- Regular monitoring of:
- Renal function and electrolytes
- Blood pressure
- Medication adherence
- Development of symptoms indicating progression to Stage C 1
- Repeat measurement of ejection fraction and structural remodeling is useful in patients who have had a change in clinical status or received treatment that might affect cardiac function 2
By systematically applying these diagnostic approaches, clinicians can accurately identify patients with Stage B heart failure and implement appropriate interventions to prevent progression to symptomatic heart failure.